Olalla Ramil Gómez

Dr. Olalla Ramil Gómez

Instituto de Investigación Biomédica de A Coruña (INIBIC), Spain
+1

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 June 2017 in BMC Musculoskeletal Disorders
Verified
Journal Article
Open access
PDF file
CVCarlos Vaamonde
Carlos Vaamonde
JLJesús Loureiro
Jesús Loureiro
MVMarta Noa Valcarcel-Ares
Marta Noa Valcarcel-Ares
RRRomina R. Riveiro-Naveira
Romina R. Riveiro-Naveira
OGOlalla Ramil Gómez
Olalla Ramil Gómez
MLMaría J López-Armada
María J López-Armada
Recent findings support a connection between mitochondrial dysfunction and activation of inflammatory pathways in articular cells. This study investigates in vivo in an acute model whether intra-articular administration of oligomycin, an inhibitor of mitochondrial function, induces an oxidative and inflammatory response in rat knee joints. Oligomycin was injected into the rat left knee joint on days 0, 2, and 5 before joint tissues were obtained on day 6. The right knee joint served as control. Results were evaluated by macroscopy and histopathology and by measuring cellular and mitochondrial reactive oxygen species (ROS), 4-hydroxy-2-nonenal (4-HNE, a marker of lipid peroxidation), nuclear factor erythroid 2-related factor 2 (Nrf2), and CD68 (macrophages) and chemokine levels. The marker of mitochondrial mass COX-IV was also evaluated. The macroscopic findings showed significantly greater swelling in oligomycin-injected knees than in control knees. Likewise, the histological score of synovial damage was also increased significantly. Immunohistochemical studies showed high expression of IL-8, coinciding with a marked infiltration of polymorphonuclears and CD68+ cells in the synovium. Mitochondrial mass was increased in the synovium of oligomycin-injected joints, as well as cellular and mitochondrial ROS production, and 4-HNE. Relatedly, expression of the oxidative stress-related transcription factor Nrf2 was also increased. As expected, no histological differences were observed in the cartilage; however, cytokine-induced neutrophil chemoattractant-1 mRNA and protein expression were up-regulated in this tissue. Mitochondrial failure in the joint is able to reproduce the oxidative and inflammatory status observed in arthritic joints.

12 January 2022 in Carbohydrate Polymers
Verified
Journal Article
Open access
MPMARIA PIÑEIRO-RAMIL
MARIA PIÑEIRO-RAMIL
FNFlórez-Fernández Noelia
Flórez-Fernández Noelia
OGOlalla Ramil Gómez
Olalla Ramil Gómez
M. D. TorresM. D. Torres
M. D. Torres
HDHerminia Dominguez
Herminia Dominguez
CVCarlos Vaamonde
Carlos Vaamonde
Synovial fibrosis is a pathological process which contributes to joint pain and stiffness in several musculoskeletal disorders. Fucoidans, sulfated polysaccharides found in brown algae, have recently emerged as promising therapeutic agents. Despite the increasing amount of evidence suggesting the protective role of fucoidans in different experimental approaches of human fibrotic disorders, the effect of these sulfated polysaccharides on synovial fibrosis has not been investigated yet. By an in vitro experimental approach in fibroblast-like synoviocytes, we detected that fucoidans inhibit their differentiation into myofibroblasts with tumor cell-like characteristics and restore apoptosis. Composition and structure of fucoidan appear to be critical for the detected activity. Furthermore, protective effects of these sulfated polysaccharides are mediated by upregulation of nitric oxide production and modulation of TGF-β/smad pathway. Altogether, our results support the use of fucoidans as therapeutic compounds in the treatment of the fibrotic processes involved in rheumatic pathologies.

13 March 2021 in Antioxidants
Verified
Journal Article
Open access
PDF file
OGOlalla Ramil Gómez
Olalla Ramil Gómez
ARAna Rodríguez-Carmona
Ana Rodríguez-Carmona
JFJennifer Adriana Fernández-Rodríguez
Jennifer Adriana Fernández-Rodríguez
MPMiguel Pérez-Fontán
Miguel Pérez-Fontán
TFTamara Ferreiro-Hermida
Tamara Ferreiro-Hermida
MLMaría J López-Armada
María J López-Armada
Preservation of the peritoneal membrane is an essential determinant of the long-term outcome of peritoneal dialysis (PD). Epithelial-to-mesenchymal transition (EMT) plays a central role in the pathogenesis of PD-related peritoneal membrane injury. We hypothesized that mitochondria may be implicated in the mechanisms that initiate and sustain peritoneal membrane damage in this setting. Hence, we carried out ex vivo studies of effluent-derived human mesothelial cells, which disclosed a significant increase in mitochondrial reactive oxygen species (mtROS) production and a loss of mitochondrial membrane potential in mesothelial cells with a fibroblast phenotype, compared to those preserving an epithelial morphology. In addition, in vitro studies of omentum-derived mesothelial cells identified mtROS as mediators of the EMT process as mitoTEMPO, a selective mtROS scavenger, reduced fibronectin protein expression induced by TGF-ß1. Moreover, we quantified mitochondrial DNA (mtDNA) levels in the supernatant of effluent PD solutions, disclosing a direct correlation with small solute transport characteristics (as estimated from the ratio dialysate/plasma of creatinine at 240 min), and an inverse correlation with peritoneal ultrafiltration. These results suggest that mitochondria are involved in the EMT that human peritoneal mesothelial cells suffer in the course of PD therapy. The level of mtDNA in the effluent dialysate of PD patients could perform as a biomarker of PD-induced damage to the peritoneal membrane.

4 November 2022 in Antioxidants
Verified
Journal Article
Open access
PDF file
OGOlalla Ramil Gómez
Olalla Ramil Gómez
MLMirian López-Pardo
Mirian López-Pardo
JFJennifer Adriana Fernández-Rodríguez
Jennifer Adriana Fernández-Rodríguez
ARAna Rodríguez-Carmona
Ana Rodríguez-Carmona
TPTeresa Pérez-López
Teresa Pérez-López
MLMaría J López-Armada
María J López-Armada
Recent studies have related mitochondrial impairment with peritoneal membrane damage during peritoneal dialysis (PD) therapy. Here, we assessed the involvement of mitochondrial dysfunction in the inflammatory response in human mesothelial cells, a hallmark in the pathogenesis of PD-related peritoneal membrane damage. Our ex vivo studies showed that IL-1β causes a drop in the mitochondrial membrane potential in cells from peritoneal effluent. Moreover, when mitochondrial damage was induced by inhibitors of mitochondrial function, a low-grade inflammatory response was generated. Interestingly, mitochondrial damage sensitized mesothelial cells, causing a significant increase in the inflammatory response induced by cytokines, in which ROS generation and NF-κB activation appear to be involved, since inflammation was counteracted by both mitoTEMPO (mitochondrial ROS scavenger) and BAY-117085 (NF-κB inhibitor). Furthermore, the natural anti-inflammatory antioxidant resveratrol significantly attenuated the inflammatory response, by reversing the decline in mitochondrial membrane potential and decreasing the expression of IL-8, COX-2 and PGE2 caused by IL-1β. These findings suggest that IL-1β regulates mitochondrial function in mesothelial cells and that mitochondrial dysfunction could induce an inflammatory scenario that sensitizes these cells, causing significant amplification of the inflammatory response induced by cytokines. Resveratrol may represent a promising strategy in controlling the mesothelial inflammatory response to PD.

1 June 2018 in Annals of the Rheumatic Diseases
Verified
Journal Article
Open access
PDF file
JFJ.A. Fernández-Rodríguez
J.A. Fernández-Rodríguez
MAM. Almonte-Becerril
M. Almonte-Becerril
OGOlalla Ramil Gómez
Olalla Ramil Gómez
SVS. Viñas-Diz
S. Viñas-Diz
LHL. Hermida-Carballo
L. Hermida-Carballo
MLMaría J López-Armada
María J López-Armada
Background Previously, we have demonstrated that dietary supplementation with resveratrol (RSV) lowers synovial hyperplasia, chemokines and oxidative damage in an acute antigen-induced arthritis (AIA) model developed in rats, and that autophagic cell death and limiting angiogenic response were involved1. Objectives Here, we investigated the autophagic flux induced by RSV and its relation with serum interleukin (IL)−1β levels, since autophagy could regulate IL-1β via inflammasome. Moreover, C-reactive protein (CRP) and prostaglandin E2 (PGE2), which are also closely linked to inflammation and correlated with disease activity, were also evaluated. Methods Animals were randomly divided into 3 groups: healthy, AIA, and RSV-treated AIA group. RSV (12,5 mg/kg/day) was given orally 8 weeks before AIA induction until sacrifice day (48 hour after intra-articular injection). Healthy and AIA animals were administered 100 µl of water. RSV effects on autophagy were evaluated by the expression of the autophagy proteins, microtubule-associated protein 1 light chain 3 (LC3), and Beclin1 (an autophagic-related protein which up-regulation is associated with increased autophagosome formation), and p62 (an autophagic adaptor protein whose accumulation is associated with autophagic degradation dysfunction), by confocal and immunohistochemistry, respectively. Specific enzyme-linked immunosorbent assay kits and cytokine magnetic milliplex were used to measure CRP and PGE2 and IL-1β in serum samples, respectively. Results At the end of the study, RSV significantly reduced the serum levels of IL-1 β, CRP and PGE2 (p≤0.01 for IL-1β and PCR, and p≤0.05 for PGE2). In relation to autophagy proteins, results showed that the expression of LC3 was greater in the AIA synovial membranes than in control synovial samples, in which the presence of vesicles was easily observed. Interestingly, the synovial tissues from the RSV group showed a significatively (p≤0.001) higher signal for LC3, compared with the AIA samples. As compared with healthy controls, AIA synovial membranes showed increased p62 expression, which was markedly inhibited by RSV treatment (p≤0.01). The protein level of Beclin 1 was higher in AIA synovial membranes than in healthy samples; however, RSV did not increase the signal of Beclin 1. Moreover, there was a significant correlation between p62 expression and serum IL-1β levels (p≤0.05 and r=0.617), PGE2 (p≤0.01 and r=0. 604), and PCR (p≤0.001 and r=0.692). Conclusions These data suggest that resveratrol is capable of inducing the non-canonical (Beclin1 independent) autophagy pathway, and in consequence, modulates the cross-talk existence with inflammation in an acute AIA model, which could also ameliorate the severity of rheumatoid arthritis. Reference [1] Riveiro-Naveira R, Valcárcel N, Almonte M, Vaamonde C, Hermida L, López E, Blanco F, López-Armada MJ. Resveratrol lowers synovial hyperplasia, inflammatory markers and oxidative damage in an acute antigen-induced arthritis model. Rheumatology2016;55(10):1889–900. Disclosure of Interest None declared

23 October 2026 in medRxiv
Verified
Preprint
Open access
PDF file
VCValentina Calamia
Valentina Calamia
PFPatricia Fernandez
Patricia Fernandez
SRSelva Riva-Mendoza
Selva Riva-Mendoza
PQPatricia Quaranta
Patricia Quaranta
BRBeatriz Rocha
Beatriz Rocha
FBFrancisco Blanco
Francisco Blanco
Background: Accurate amyloid subtyping is essential for patient management but remains challenging with antibody-based methods. We prospectively evaluated a standardized LC-MS/MS workflow for routine amyloid typing, focusing on diagnostic yield, operational performance, and added value in cases not fully resolved by conventional methods. Methods: From 2020 to 2025, 115 FFPE biopsies from patients with suspected amyloidosis were analyzed at Hospital Universitario A Coruña, Spain, without laser microdissection. Proteins were identified and quantified using PEAKS, with a peak-area cutoff ≥10 5 for candidate fibril proteins. Results: Seventy-nine cases (69%) were amyloid-positive, 22 (19%) negative and 14 (12%) indeterminate. AL (51%), ATTR (32%) and AA (10%) predominated, with additional AH (5%), mixed ATTR+AL, hereditary ATTRv and AIns amyloidoses. Binary concordance with conventional techniques ranged from 85.7% to 91.5%. LC-MS/MS provided additional diagnostic information in 64/110 evaluable cases (58.2%), including additional subtyping information in 53/110 (48.2%). The workflow also enabled relative quantification of variant versus wild-type TTR peptides and characterization of SAA post-translational modifications. Mean turnaround time was approximately two weeks and MS findings informed clinical management. Conclusions: LC-MS/MS amyloid typing was clinically feasible in routine FFPE biopsies without laser microdissection and supported identification of common, rare and mixed amyloid types.